NuroKor is committed to the development of bioelectronic technologies. We’re evidence-led, research-driven, with proven healthcare applications and our devices are CE-marked and FDA-cleared to deliver personalised treatment for certain conditions.

Through this series of blogs, we’re exploring how we think about NuroKor in the context of healthcare and clinicians, shining a light on the potential impact of electrotherapy for people living with health challenges. Our last post addressed our belief in evidence-led biotechnology and in this article, we’ll share how our own research is placing us at the forefront of the research into bioelectric medicine.

Our research ventures

Existing evidence shows that our technology has the power to boost muscle function and recovery by reducing pain, impacting inflammation and generally improving fitness in older populations. Although the science behind NuroKor meets the highest standards of evidence, the full potential of the technology is yet to be fully realised by the available research.

To ensure that we contribute and further the field, we currently have several ongoing studies concentrating on the use of bioelectric therapy, beginning with optimising muscle recovery.

We want to make sure that any assessment with our technology is done independently and so we partner with universities to ensure this impartiality. Through our current University research collaborations, we are developing a 20-person study that looks at the reduction of Delayed Onset Muscle Soreness (DOMS) and the ability of NuroKor devices to boost lactate removal and raise post-intervention VO2 Max. We intend to demonstrate the science behind why our devices can help us all age healthier and how we can turn up the power for athletes, physical therapists and everyone that trains hard and competes fast.

Our research plans don’t end there. We have further studies planned with multiple distinguished University research centres, that are focused on exploring electrotherapy in healthy ageing and in musculoskeletal disease.

Beyond human

Bioelectric medicine has the potential to revolutionise more than just human medicine. For this reason, we are also actively engaged in veterinary science research. The NuroKor Equine Study will assess the efficacy of sequential, multi-frequency microcurrents delivered by our EquiPod device in order to improve healing rates and functional outcomes for horses. It is thought that the results of this study will provide support for multi-frequency microcurrents as an effective tool for post-operative recovery, and to highlight the possibility of its application for other types of equine conditions, injuries, and surgeries.

This research into the post-operative recovery benefits of bioelectric medicine in horses is the first of its kind and places NuroKor firmly at the forefront of innovative biotechnological research.

We’re at the very beginning of brand new bioelectric technologies that have the potential to make real change in the lives of so many and through our research, we’re furthering the field to ensure that this technology is applied safely and to its maximum efficacy. In our next article, we’ll be explaining how our technology may provide a cost-effective, drug-free alternative to conventional medication…

Further information detailing our University research and partnership collaborations to be released in tentative media release. Please contact, media@nurokor.co.uk with any enquiries or with opportunities for future collaboration.

‍

About NuroKor:

Founded in 2018, NuroKor is a company committed to the development of bioelectronic technologies. NuroKor develops and formulates programmable bioelectronic software for clinical and therapeutic applications, in a range of easy to use, wearable devices. It provides the highest-quality products, delivering personalised pain relief and recovery support and rehabilitation to patients.

‍